Firefly Neuroscience AIFF stock jumps 35% after partnering with NeuroSigma to expand access to FDA-cleared Monarch ADHD therapy through clinicians.
Firefly Neuroscience Inc. (AIFF) Stock: Surges 35% After NeuroSigma ADHD Therapy Partnership
view original post